Microbial induction of immunity, inflammation, and cancer
- PMID: 21423403
- PMCID: PMC3059938
- DOI: 10.3389/fphys.2010.00168
Microbial induction of immunity, inflammation, and cancer
Abstract
The human microbiota presents a highly active metabolic that influences the state of health of our gastrointestinal tracts as well as our susceptibility to disease. Although much of our initial microbiota is adopted from our mothers, its final composition and diversity is determined by environmental factors. Westernization has significantly altered our microbial function. Extensive experimental and clinical evidence indicates that the westernized diet, rich in animal products and low in complex carbohydrates, plus the overuse of antibiotics and underuse of breastfeeding, leads to a heightened inflammatory potential of the microbiota. Chronic inflammation leads to the expression of certain diseases in genetically predisposed individuals. Antibiotics and a "clean" environment, termed the "hygiene hypothesis," has been linked to the rise in allergy and inflammatory bowel disease, due to impaired beneficial bacterial exposure and education of the gut immune system, which comprises the largest immune organ within the body. The elevated risk of colon cancer is associated with the suppression of microbial fermentation and butyrate production, as butyrate provides fuel for the mucosa and is anti-inflammatory and anti-proliferative. This article will summarize the work to date highlighting the complicated and dynamic relationship between the gut microbiota and immunity, inflammation and carcinogenesis.
Keywords: allergy; colon cancer; diet; inflammatory bowel disease; microbiota.
Figures


Similar articles
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
-
Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.World J Gastroenterol. 2014 Dec 28;20(48):18121-30. doi: 10.3748/wjg.v20.i48.18121. World J Gastroenterol. 2014. PMID: 25561781 Free PMC article. Review.
-
Prebiotic effects: metabolic and health benefits.Br J Nutr. 2010 Aug;104 Suppl 2:S1-63. doi: 10.1017/S0007114510003363. Br J Nutr. 2010. PMID: 20920376 Review.
-
Intestinal microbiota in inflammatory bowel disease: friend of foe?World J Gastroenterol. 2011 Feb 7;17(5):557-66. doi: 10.3748/wjg.v17.i5.557. World J Gastroenterol. 2011. PMID: 21350704 Free PMC article.
-
Linking the Gut Microbial Ecosystem with the Environment: Does Gut Health Depend on Where We Live?Front Microbiol. 2017 Oct 6;8:1935. doi: 10.3389/fmicb.2017.01935. eCollection 2017. Front Microbiol. 2017. PMID: 29056933 Free PMC article.
Cited by
-
New insights in gut microbiota establishment in healthy breast fed neonates.PLoS One. 2012;7(8):e44595. doi: 10.1371/journal.pone.0044595. Epub 2012 Aug 30. PLoS One. 2012. PMID: 22957008 Free PMC article.
-
Angiotensin and systems thinking: wrapping your mind around the big picture.Ochsner J. 2013 Spring;13(1):11-25. Ochsner J. 2013. PMID: 23533336 Free PMC article. No abstract available.
-
The Evaluation of Beta-2-Adrenoreceptors' Expression in Normal Peritumoral Tissue in Patients with Colorectal Adenocarcinoma.Curr Health Sci J. 2016 Oct-Dec;42(4):335-341. doi: 10.12865/CHSJ.42.04.01. Epub 2016 Feb 28. Curr Health Sci J. 2016. PMID: 30581586 Free PMC article.
-
Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral Absorption.Front Nutr. 2021 Jul 27;8:672925. doi: 10.3389/fnut.2021.672925. eCollection 2021. Front Nutr. 2021. PMID: 34386514 Free PMC article. Review.
-
The role of gut microbiota in the pathogenesis of colorectal cancer.Tumour Biol. 2013 Jun;34(3):1285-300. doi: 10.1007/s13277-013-0684-4. Epub 2013 Feb 10. Tumour Biol. 2013. PMID: 23397545 Review.
References
-
- Ananthakrishnan A. N., Issa M., Binion D. G. (2009). Clostridium difficile and inflammatory bowel disease. Gastroenterol. Clin. North Am. 38, 711–728 - PubMed
-
- Angulo S., Llopis M., Antolin M., Gironella M., Sans M., Malagelada J. R., Pique J. M., Guarner F., Panes J. (2006). Lactobacillus casei prevents the upregulation of ICAM-1 expression and leukocyte recruitment in experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G1155–G1162. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources